publication venue for
- Management of heparin-induced thrombocytopenia. 23:462-470. 2016
- Prophylactic platelet transfusions. 21:521-527. 2014
- Bone marrow localization and functional properties of human hematopoietic stem cells. 21:249-255. 2014
- Treatment with novel oral anticoagulants. 20:430-436. 2013
- Complement and the antiphospholipid syndrome. 18:361-365. 2011
- Roles for MSI2 and PROX1 in hematopoietic stem cell activity. 18:203-207. 2011
- A logical approach to surgical thromboprophylaxis. 16:397-401. 2009
- Signal control of hematopoietic stem cell fate: Wnt, Notch, and Hedgehog as the usual suspects. 15:319-325. 2008
- Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction?. 6:600-606. 2007
- Antiphospholipid antibiodies: a critical review of the literature. 14:494-499. 2007
- Hormone replacement therapy and risk for venous thromboembolism: what??s new and how do these findings influence clinical practice?. 4:649-654. 2005
- Transfusion-related acute lung injury. 12:480-487. 2005
- Fondaparinux, the first selective factor Xa inhibitor. 10:327-332. 2003
- Inherited platelet disorders. 10:362-368. 2003
- Pathophysiology of febrile nonhemolytic transfusion reactions. 6:420-420. 1999
- Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins. 5:B159-B159. 1998
- Thrombosis in pregnancy. 4:335-343. 1997
- Febrile nonhemolytic transfusion reactions to platelets. 2:478-483. 1995
- Multimerin. 2:339-344. 1995